Eads & Heald Wealth Management’s Organon & Co OGN Stock Holding History

Eads & Heald Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,760	Closed	-$206K	–	143
2024 Q3	$206K	Buy	10,760 +340	+3%	+$7.05K	0.1%	141
2024 Q2	$216K	Buy	+10,420	New	+$207K	0.1%	140
2023 Q2	–	Sell	-8,830	Closed	-$208K	–	148
2023 Q1	$208K	Buy	+8,830	New	+$237K	0.1%	140

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eads & Heald Wealth Management's OGN Position: Q4 2024 in Review

Eads & Heald Wealth Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 10,760 shares — an estimated $206K sold.

Eads & Heald Wealth Management first reported a position in OGN in Q1 2023 and held it in 3 quarters. The position peaked at $216K in Q2 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

Eads & Heald Wealth Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
Eads & Heald Wealth Management sold 10,760 Organon & Co shares in Q4 2024, an estimated $206K.
Eads & Heald Wealth Management first reported a position in Organon & Co in Q1 2023 and held it in 3 quarters.
Eads & Heald Wealth Management's Organon & Co position peaked at $216K in Q2 2024.
740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2024, filed 17 Jan 2025.